Sucampo Pharmaceuticals is Pharmaceuticals in United States that focus on opioid-induced constipation business. Founded in 1996. They cover business area such as manufacturer, developer, specialized medicine, commercialization, drug, prostone, compound, functional fatty acid, chronic and idiopathic constipation, irritable bowel syndrome, opioid-induce constipation, adult patient, their life.
1996
( 28 years old in 2024 )
Opioid-induced Constipation
-
805 King Farm Boulevard
Suite 550
Rockville, MD 20850
United States
Private
manufacturerdeveloperspecialized medicinecommercializationdrugprostonecompoundfunctional fatty acidchronic and idiopathic constipationirritable bowel syndromeopioid-induce constipationadult patienttheir life
* We use standard office opening hours in near Sucampo Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sucampo Pharmaceuticals is Pharmaceuticals business from United States that founded in 1996 (28 years old in 2024), Sucampo Pharmaceuticals business is focusing on Opioid-induced Constipation.
Sucampo Pharmaceuticals headquarter office and corporate office address is located in 805 King Farm Boulevard Suite 550 Rockville, MD 20850 United States.
Sucampo Pharmaceuticals was founded in United States.
In 2024, Sucampo Pharmaceuticals is currently focus on opioid-induced constipation sector.
Above is snippet of Google Trends for "opioid-induced constipation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sucampo Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
